Hospital floor, person with mask and protection suit, walking, unfixing the mask, two more people in the back, 06/2015, (General, Photography, Doctor/Physician, Hospital)

icon-infectious-disease-testing

COVID-19

Diagnostic testing

Multiplex PCR

Syndromic testing with QIAstat-Dx

To support the efforts for accessible testing to meet the demands of the COVID-19 outbreak, QIAGEN has developed the QIAstat-Dx Respiratory SARS-CoV-2 Panel. This version of our multiplex syndromic cartridge enables detection of the SARS-CoV-2 virus that causes COVID-19 in addition to 20+ other respiratory pathogens.*

Discover Qiastat-Dx

QIAstat-Dx, QIAstat-Dx analyzer, syndromic testing, instrument, cartridge QIAstat-Dx, QIAstat-Dx analyzer, syndromic testing, instrument, cartridge, technician, woman, lab tech, lab, laboratory

*The number of targets/pathogens detected by the QIAstat-Dx Respiratory SARS-CoV-2 Panels is different in different countries.

Targeted PCR

NeuMoDx, NMDx, N96, N288, NeuMoDx 96, NeuMoDx 288, automation, infectious disease, IDx, molecular diagnostics, MDx, instrument

Rapid, high-throughput targeted testing with NeuMoDx

The NeuMoDx 96 and NeuMoDx 288 systems offer two rapid and fully automated PCR tests for the detection of SARS-CoV-2, under FDA Emergency Use Authorization, that can deliver a result within an hour. A new multiplex test for influenzas A/B, respiratory syncytial virus (RSV) and the SARS-CoV-2 virus is now available. NeuMoDx systems provide an ideal solution for hospitals or central testing labs, delivering the speed and flexibility to support the large numbers of patient samples they receive.

Discover NeuMoDx

Antigen

Coming soon: Scalable, digital SARS-CoV-2 infection testing

QIAGEN is developing the QIAreach SARS-CoV-2 Antigen Test, a scalable, digital assay for the in vitro detection of the SARS-CoV-2 nucleocapsid protein antigen.

The QIAreach SARS-CoV-2 Antigen Test will let you test up to eight patients at once for SARS-CoV-2 infection – with first positive results in just two minutes.

Discover QIAREACH SARS-COV-2 ANTIGEN TEST

The QIAreach SARS-CoV-2 Antigen Test is currently under development and is coming soon.

Antibody

Access eHub Tests, instrument, Anti-CoV2, eSticks, Processing tubes, sample, Immune Response, Access Anti-SARS-CoV-2 Total, rapid, qualitative detection of total antibodies to SARS-CoV-2, digital lateral flow serological test, nanoparticle fluorescence, qualitative detection of total antibodies to SARS-CoV-2 in human serum and plasma (heparin, EDTA)

The QIAreach Anti-SARS-CoV-2 Total Test is currently under development and is coming soon.

Detect SARS-CoV-2 antibodies in just three minutes

To enable accessible and accurate SARS-CoV-2 antibody testing, QIAGEN is developing the QIAreach Anti-SARS-CoV-2 Total Test (Anti-CoV2). The Anti-CoV2 test will enable rapid, qualitative detection of total antibodies to SARS-CoV-2. Features include Total Ig detection (IgA, IgM, and IgG), results in approximately 10 minutes, and the ability to test up to 8 patients simultaneously on the digital QIArearch eHub.

Discover QIAREACH ANTI-SARS-COV-2 TOTAL TEST

The complete QIAreach solution

The QIAreach eHub sets new standards in throughput and flexibility for SARS-CoV-2 testing. This digital portable device was designed for ease of use, reliability and integrated data management. Using the eStick system, it can run both the QIAreach Anti-SARS-CoV-2 Total Test and QIAreach SARS-CoV-2 Antigen Test interchangeably.

Emergency protocols

scientist, laboratory, labworker, check, reaserch, monitor, round, machine, instrument, female asian scientist in a lyb inviroment wearing a mask

QIAGEN support in testing protocols for emergency use

QIAGEN supports several testing protocols, including U.S. CDC, WHO, China CDC and Japan CDC, by providing test components, mid- to high-throughput automation solutions, and a multiplex syndromic detection solution.

Product availability varies by country. Please contact your country representative or complete the support request form for further details. Please also review the protocols themselves for alternative solutions from other suppliers.

For QIAcube classic information please visit our resource hub.

RNA extraction

RNA extraction solutions

Given the current public health emergency with COVID-19, QIAGEN and other companies are facing unprecedented demand for viral RNA isolation solutions. QIAGEN has developed dedicated solutions for viral RNA isolation that have been optimized for maximum sensitivity and reproducibility.

We recognize that currently, scientists are seeking to use various QIAGEN kits, such as RNeasy, for SARS-CoV-2 RNA isolation from respiratory samples. It is critical to note that these kits have not been designed for isolating viral RNA, and performance of each kit varies. The user must consult the product-specific handbook or user manual. We strongly recommend using only dedicated RNA isolation products for SARS-CoV-2, such as those listed below:

Solutions authorized for use for COVID-19 testing in some regions (please check local regulations)

group of scientist, talk, discussion, laboratory, diversity, wearing masks

For QIAcube classic information please visit our resource hub.

Custom reagents

Tailored oligonucleotides for SARS-CoV-2 detection

In our effort to support the detection of the SARS-CoV-2 virus, OEM by QIAGEN has ramped up the production of SARS-CoV-2 specific primers and probes. We provide customized oligos defined by our customers, as well as those mentioned in protocols recommended by WHO and the CDC. To meet the high demands, we are currently prioritizing the orders of SARS-CoV-2 specific oligonucleotides. In addition, we have introduced pre-manufacturing of these oligonucleotides to enable quick supply and delivery. To order, please send your requests here.

Discover OEM by QIAGEN

Additional COVID-19 resources

Research solution for COVID-19
Learn how QIAGEN can support research to better understand the SARS-CoV-2 virus.
read more
Latest COVID-19 updates from QIAGEN
Stay up-to-date with our latest news and product developments here.
read more
Battling tuberculosis in the time of COVID-19
Dr. Story brings tuberculosis testing and treatment to susceptible homeless communities during COVID-19.
read more

QIAGEN solutions

QIAstat-Dx
The next generation of syndromic insights
Harness the full potential of multiplex syndromic testing and confidently provide clinical insights to patients with the highest level of versatility.
FIND OUT MORE
QIAGEN Digital Insights
Bioinformatics analysis of SARS-CoV-2 with QIAGEN Digital Insights
To support the efforts of labs sequencing the SARS-CoV-2 virus on the front lines of the COVID-19 pandemic, QIAGEN is offering free temporary licenses to researchers worldwide involved with COVID-19 research and response.
FREE TEMPORARY LICENSE
QIAcube Connect
Redefining automated sample processing
Fully automate QIAGEN gold-standard spin-column purification procedures with the new QIAcube Connect instrument.
VIEW DEMO
EZ1 DSP Virus Kit
Contains all required reagents for automated purification
The EZ1 DSP Virus Kit is ideal for automated, simultaneous purification of viral nucleic acids and bacterial DNA from 1–6 or 1–14 human biological specimens.
FIND OUT MORE
QIAamp Viral RNA Mini Kit
For isolation of viral RNA from cell-free body fluids
By binding viral RNA to the QIAamp silica membrane, the QIAamp Viral RNA Mini Kit simplifies purification of viral RNA from cell-free body fluids with fast spin-column or vacuum procedures. The procedure can be fully automated.
FIND OUT MORE
QIAstat Respiratory SARS-CoV-2 Panel
Accessible testing to meet the demands of the COVID-19 outbreak
This expanded version of our multiplex respiratory cartridge detects and differentiates 22 viral and bacterial respiratory targets, including SARS-CoV-2.
FIND OUT MORE
EZ1 Advanced XL
For automated nucleic acid purification
With EZ1 Advanced XL you can fully automate your nucleic acid purification from a wide range of sample types relevant for molecular diagnostics.
FIND OUT MORE

icon-support

How can we support your lab?

Reach a specialist about SARS-CoV-2 resources.

LET US KNOW

möLab GmbH is the manufacturer of the mö-screen Corona Antigen Test. QIAGEN is a distributor.

For up-to-date licensing information and product-specific disclaimers, see the respective QIAGEN/NeuMoDx kit handbook or user operator manual. QIAGEN handbooks and user manuals are available at www.qiagen.com or can be requested from QIAGEN Technical Services (or your local distributor) or www.neumodx.com/client-resources.